Hepatitis B test kit DDK-HMM-0001

DNA extractionfor researchvirus

Product Overview
This kit is intended for monitoring HBV DNA baseline and dynamics in hepatitis B patients receiving antiviral therapy to assess treatment response and efficacy.

Intended Use
In vitro quantitative detection of Hepatitis B virus (HBV) DNA in human serum or plasma samples.

Key Features

• Exogenous internal standard monitors the entire process from DNA extraction to PCR amplification to reduce false negatives caused by inhibitors or operational errors.
• UDG enzyme anti-contamination measures are implemented to prevent false positives from product contamination.

Sample Type and Method
Sample Type: Serum or plasma.
Detection Method: Fluorescent PCR method.

Notes
For research use only, not for clinical use.

Technical Specifications

• Product Name: Hepatitis B Virus Nucleic Acid Test Kit (Fluorescent PCR Method)
• Catalog No.: BDDK-HMM-0001
• Description: Designed to monitor HBV DNA baseline and changes to assess response to antiviral therapy and monitor treatment efficacy in hepatitis B patients.
• Disease Type: Hemovirus disease
• Applications: In vitro quantitative detection of HBV DNA in human serum/plasma samples.
• Sample Type: Serum or plasma
• Detection Method: Fluorescent PCR method
• Sensitivity: Minimum detection limit 5 IU/mL
• Detection Range: 10-1.0×10^9 IU/mL
• Accuracy: Absolute deviation of quantitative values < 0.5; coefficient of variation < 5%
• Storage: Store at -20°C away from light
• Shelf Life: 9 months
• Available Quantities: 24T and 48T